Sep 16, 2020

Creoptix "Under the Microscope" with leadXpro

Transforming drug discovery on membrane proteins - together


Our CEO, Line Stigen Raquet, and Michael Hennig from leadXpro sat together and discussed why the company chose the WAVE's GCI (Grating-Coupled Interferometry) technology back in 2017. Discovery how this partnership is creating first‑of‑a‑kind kinetic data. Read all about it on Drug Target Review.